Anti-Nectin-4 Reference Antibody (enfortumab vedotin-ejfv)

• Catalog Number: orb1805477
• Category: Antibodies
• Description: Anti-Nectin-4 Reference Antibodyd antibody and Monomethyl auristatin E (MMAE) , suitable for adult patients with locally advanced or metastatic urothelial carcinoma, or who have received programmed cell death protein 1 (PD-1) inhibitor or programmed cell death ligand 1 (PD-L1) inhibitor therapy or neoadjuvant/adjuvant platinum-based chemotherapy for locally advanced or metastatic cancer.
• Target: Nectin-4
• Clonality: Monoclonal
• Isotype: IgG
• Conjugation: Unconjugated
• Reactivity: Human
• Buffer/Preservatives: 100 mM Proline/Acetic acid 20 mM Arginine pH 5.0
• Purity: > 95%
• MW: 145.44 kDa
• Tested applications: ELISA, FA, FACS, Kinetics
• Endotoxins: < 1 EU/mg
• Storage: Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
• Note: For research use only

Anti-Nectin-4 Reference Antibody (enfortumab vedotin-ejfv) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.

The purity of Anti-Nectin-4 Reference Antibody (enfortumab vedotin-ejfv)is more than 100% ;determined by SEC-HPLC.

Immobilized human NECTIN 4 His at 2 μg/mL can bind Anti-Nectin-4 Reference Antibody (enfortumab vedotin-ejfv);EC50=0.003846μg/mL.